Press Releases
SFMS Announces Investigation Into Gentiva Health Services’ Acquisition Of Odyssey Healthcare
Shepherd, Finkelman, Miller & Shah, LLP (“SFMS”) ( http://www.sfmslaw.com) is investigating the agreement under which Gentiva Health Services (“Gentiva”) (Nasdaq: GTIV) intends to acquire Odyssey Healthcare, Inc. (“Odyssey Healthcare”) (Nasdaq: ODSY). Odyssey Healthcare, based in Dallas, Texas, provides hospice care for patients. Gentiva, with headquarters in Atlanta, Georgia, provides home health services. The agreement, announced on May 24, 2010, would allow Gentiva to acquire Odyssey Healthcare for $27.00 per share, or approximately $1.1 billion for the transaction. SFMS’ investigation of the agreement concerns whether there has been adequate disclosure to shareholders concerning the terms of the acquisition and whether the compensation offered to Odyssey Healthcare shareholders pursuant to the acquisition is adequate. The transaction is expected to be completed in the third quarter of 2010.
If you own shares of Odyssey Healthcare and would like to request additional information about this investigation, please contact Karen M. Leser-Grenon at kleser@sfmslaw.com or toll-free at 866-540-5505 (ext. 206) or Patrick A. Klingman at pklingman@sfmslaw.com or toll-free at 866-540-5505 (ext. 205). Shepherd, Finkelman, Miller & Shah, LLP ( http://www.sfmslaw.com) is a law firm that represents consumers, fiduciaries, beneficiaries and investors, including institutions and individuals, in class action and other complex litigation, and maintains offices in California, Connecticut, Florida, New Jersey, Pennsylvania and Wisconsin. The firm’s attorneys have experience prosecuting cases on behalf of shareholders in mergers and acquisitions throughout the United States. Attorney Advertising. Prior results do not guarantee a similar outcome.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |



Connect with TheStreet